2014 Vol.32, N°6 - Suppl.87 - Table of contents

LER & CER - Letter to Editor Rheumatology: Commentaries and Controversies

Guest Editors: H. Yazici, T. Pincus, M. Boers

LER & CER: letter to Editor Rheumatology

CER7244
2014,32,6,Suppl.87
Pg. 0003

Free to view

Analysis of intrinsic biomechanical factors are needed to identify parameters that may predict benefit from lateral wedge orthotics in medial knee osteoarthritis. Comment on the article by Parkes MJ, et al.
B. Goker, J.A. Block, R.H. Lidtke

CER7239
2014,32,6,Suppl.87
Pg. 0004

Free to view

Monotherapy for rheumatoid arthritis treatment?
Y. Yazici

CER7238
2014,32,6,Suppl.87
Pg. 0005-0006

Free to view

Erosions are like cockroaches, when you see one there are many others you do not see. It`s just one erosion! No, it is not!
J.A. Goldman

CER7615
2014,32,6,Suppl.87
Pg. 0007

Free to view

Erosions in rheumatoid arthritis: is there less here than meets the eye?
Y. Yazici

CER7626
2014,32,6,Suppl.87
Pg. 0008-0009

Free to view

Do non-steroidal anti-inflammatory drugs increase or decrease cardiovascular risk in patients with rheumatoid arthritis?
P.P. Sfikakis, V.-K. Bournia, G. Kitas

CER7636
2014,32,6,Suppl.87
Pg. 0010

Free to view

Methotrexate and not much harm to the lungs
H. Yazici

CER7788
2014,32,6,Suppl.87
Pg. 0011

Free to view

Reply to: Methotrexate and not much harm to the lungs by H. Yazici
R. Conway, C. Low, R.J. Coughlan, M.J. O`donnell, J.J. Carey

CER7789
2014,32,6,Suppl.87
Pg. 0012-0013

Free to view

Familial Mediterranean fever phenotype and MEFV variations
A. Gül

CER7804
2014,32,6,Suppl.87
Pg. 0014-0015

Free to view

ASAS classification criteria for axial spondyloarthritis: a look at the unfilled part of the glass
N. Akkoc, M.A. Khan

CER7737
2014,32,6,Suppl.87
Pg. 0016-0017

Free to view

Cardiovascular risk estimation and management in rheumatoid arthritis: comment on the EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis
G. Ozen, H. Direskeneli, N. Inanc

CER7784
2014,32,6,Suppl.87
Pg. 0018

Free to view

Is attenuated COBRA treatment strategy (COBRA-light) non-inferior or not non-inferior than original COBRA strategy?
S. Akar, M. Tinazli

CER7835
2014,32,6,Suppl.87
Pg. 0019

Free to view

Is osteoporosis a real disease?
Y. Karaaslan, I. Simsek